“Levetiracetam Plus Oxcarbazepine Combination Treatment Downregulates Serum Multidrug Resistance Protein 1 Levels and Upregulates Neuropeptide Y Levels in Children With Epilepsy”. Brazilian Journal of Pharmaceutical Sciences, vol. 59, May 2023, p. e21414, https://doi.org/10.1590/s2175-97902023e21414.